Laboratoire de Pharmacie Galénique et de Biopharmacie, Université Libre de Bruxelles, Brussels, Belgium.
Int J Pharm. 2012 May 30;428(1-2):103-13. doi: 10.1016/j.ijpharm.2012.03.002. Epub 2012 Mar 10.
The purpose of this study was to produce a dry powder for inhalation (DPI) of a poorly soluble active ingredient (itraconazole: ITZ) that would present an improved dissolution rate and enhanced solubility with good aerosolization properties. Solid dispersions of amorphous ITZ, mannitol and, when applicable, D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) were produced by spray-drying hydro-alcoholic solutions in which all agents were dissolved. These dry formulations were characterized in terms of their aerosol performances and their dissolution, solubility and physical properties. Modulate differential scanning calorimetry and X-ray powder diffraction analyses showed that ITZ recovered from the different spray-dried solutions was in an amorphous state and that mannitol was crystalline. The inlet drying temperature and, indirectly, the outlet temperature selected during the spray-drying were critical parameters. The outlet temperature should be below the ITZ glass transition temperature to avoid severe particle agglomeration. The formation of a solid dispersion between amorphous ITZ and mannitol allowed the dry powder to be produced with an improved dissolution rate, greater saturation solubility than bulk ITZ and good aerosol properties. The use of a polymeric surfactant (such as TPGS) was beneficial in terms of dissolution rate acceleration and solubility enhancement, but it also reduced aerosol performance. For example, significant dissolution rate acceleration (f(2)<50) and greater saturation solubility were obtained when introducing 1% (w/w) TPGS (mean dissolution time dropped from 50.4 min to 36.9 min and saturation solubility increased from 20 ± 3 ng/ml to 46 ± 2 ng/ml). However, the fine particle fraction dropped from 47 ± 2% to 37.2 ± 0.4%. This study showed that mannitol solid dispersions may provide an effective formulation type for producing DPIs of poorly soluble active ingredients, as exemplified by ITZ.
本研究的目的是制备一种用于吸入的干粉制剂(DPI),该干粉制剂包含一种难溶性活性成分(伊曲康唑:ITZ),以提高其溶解速率和溶解度,并具有良好的空气动力学特性。通过喷雾干燥含有溶解于其中的所有成分的醇水混合物,制备了无定形 ITZ、甘露醇和(适用时)D-α-生育酚聚乙二醇 1000 琥珀酸酯(TPGS)的固体分散体。通过调制差示扫描量热法和 X 射线粉末衍射分析发现,从不同喷雾干燥溶液中回收的 ITZ 处于无定形状态,甘露醇为结晶状态。入口干燥温度和间接选择的喷雾干燥出口温度是关键参数。出口温度应低于 ITZ 的玻璃化转变温度,以避免严重的颗粒团聚。无定形 ITZ 和甘露醇之间形成固体分散体,使干粉具有提高的溶解速率、大于 ITZ 原料药的饱和溶解度和良好的空气动力学特性。使用聚合物表面活性剂(如 TPGS)有利于提高溶解速率和增加溶解度,但也会降低空气动力学性能。例如,当引入 1%(w/w)TPGS 时,获得了显著的溶解速率加速(f(2)<50)和更高的饱和溶解度(平均溶解时间从 50.4 分钟降至 36.9 分钟,饱和溶解度从 20±3ng/ml 增加到 46±2ng/ml)。然而,细颗粒分数从 47±2%降至 37.2±0.4%。本研究表明,甘露醇固体分散体可能为制备难溶性活性成分的 DPI 提供一种有效的制剂类型,以 ITZ 为例。